Certified by Founder Lodge
Alumis
United States - South San Francisco, California
START UP
1 Disclosed Funding Rounds $259,000,000
0 Participating Investments
-
Founded date
2021
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Alumis, our goal is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.
We recognize that patients living with immune-mediated d
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 07 ,2024 | Series C | $259,000,000 |
Foresite Capital
Omega Funds
Ally Bridge Group
Nextech
Samsara BioCapital
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
